@article{7c2032acba1746a28a460e0b8308a36f,
title = "EPAS1 mutations and paragangliomas in cyanotic congenital heart disease",
author = "Anand Vaidya and Flores, \{Shahida K.\} and Cheng, \{Zi Ming\} and Marlo Nicolas and Yilun Deng and Opotowsky, \{Alexander R.\} and Louren{\c c}o, \{Delmar M.\} and Barletta, \{Justine A.\} and Rana, \{Huma Q.\} and \{Adelaide Pereira\}, M. and Toledo, \{Rodrigo A.\} and Dahia, \{Patricia L.M.\}",
note = "Funding Information: grant from the Doris Duke Charitable Foundation (2015085, to Dr. Vaidya), by a National Research Service Award Institutional Predoctoral Training Grant (T32CA148724, to Ms. Flores), by a Cancer Prevention and Research Institute of Texas (CPRIT) Training Grant (RP140105, to Dr. Deng), by a S{\~a}o Paulo Research Foundation (FAPESP) grant (2016/07504-2, to Dr. Louren{\c c}o), by a Miguel Servet-I research contract from the Institute of Health Carlos III of the Ministry of Economy and Competitiveness (CP17/00199, to Dr. Toledo), by the Olga Torres Foundation (to Dr. Toledo), by a CPRIT Individual Investigator Award (RP140473, to Dr. Dahia), and by the Greehey Children{\textquoteright}s Cancer Research Institute (GCCRI) (to Dr. Dahia). The GCCRI Genomic Sequencing Facility is supported by a grant (P30-CA54174, to the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio) and by an NIH Shared Instrument grant (1S10OD021805-01). Funding Information: Dr. Vaidya and Ms. Flores contributed equally to this letter. Supported by grants from the National Institutes of Health (NIH) (DK107407, to Dr. Vaidya; GM114102, to Dr. Dahia), by a",
year = "2018",
month = mar,
day = "29",
doi = "10.1056/NEJMc1716652",
language = "English (US)",
volume = "378",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "13",
}